Erratum: A 25-year experience with Carpentier-Edwards Perimount in the mitral position (Asian Cardiovascular & Thoracic Annals 19:1 (14-19) DOI:10.1177/0218492310395422);A 25-year experience with Carpentier-Edwards Perimount in the mitral position

Asian Cardiovascular and Thoracic Annals

Volumn 19, Issue 1, 2011, Pages 14-19

  Ayegnon, Kouakou Gregoire ^a   Aupart, Michel ^a   Bourguignon, Thierry ^a   Mirza, Alain ^a   May, Marc Antoine ^b   Marchand, Michel ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

Bioprosthesis; Follow up studies; Heart valve prosthesis implantation; Mitral valve; Survival rate

Indexed keywords

ADULT; AGED; ARTICLE; CALCIFICATION; CARPENTIER EDWARDS BIOPROSTHESIS; DEGENERATIVE DISEASE; EXPERIENCE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; MORTALITY; OVERALL SURVIVAL; REOPERATION; VALVULAR HEART DISEASE;

EID: 79955998934     PISSN: 02184923     EISSN: 02184923     Source Type: Journal    
DOI: 10.1177/0218492311412268     Document Type: Erratum

References (20)

1. Corbineau H, Du Haut Cilly FB, Langanay T, Verhoye JP and Leguerrier A. Structural durability in Carpentier-Edwards Standard bioprosthesis in mitral position: a 20-year experience. J Heart Valve Dis 2001;10:443-448. (Pubitemid 32685059)
2. Marchand M, Aupart M, Norton R, Goldsmith IR, Pelletier C, Pellerin M, et al. Twelve-year experience with Carpentier-Edwards Perimount pericardial valve in the mitral position: a multicenter study. J Heart Valve Dis 1998;7:292-298. (Pubitemid 28266850)
3. Neville PH, Aupart MR, Diemont FF, Sirinelli AL, Lemoine EM and Marchand MA. Carpentier-Edwards pericardial bioprosthesis in aortic or mitral position: a 12-year experience. Ann Thorac Surg 1998;66: S143-S147. (Pubitemid 29087149)
4. Doenst T, Borger MA and David TE. Long-term results of bioprosthetic mitral valve replacement: the pericardial perspective [Review]. J Cardiovasc Surg 2004;45:449-454. (Pubitemid 40074192)
5. Mendelson K and Schoen FJ. Heart valve tissue engineering: concepts, approaches, progress, and challenges [Review]. Ann Biomed Eng 2006;34:1799-1819. (Pubitemid 44770835)
6. Caimmi PP, Di Summa M, Galloni M, Gastaldi L, Papillo B, Actis-Dato GM, et al. Twelve-year follow up with the Sorin Pericarbon bioprosthesis in the mitral position. J Heart Valve Dis 1998;7:400-406. (Pubitemid 28351305)
7. Chambers J and Ely JL. Early postoperative echocardiographic hemodynamic performance of the On-X prosthetic heart valve: a multicenter study. J Heart Valve Dis 1998;7:569-573. (Pubitemid 28435395)
8. Edmunds Jr LH, Clark RE, Cohn LH, Grunkemeier GL, Miller DC and Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American Association for Thoracic Surgery, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Ann Thorac Surg 1996;62:932-935.
9. Aupart MR, Neville PH, Hammami S, Sirinelli AL, Meurisse YA and Marchand MA. Carpentier-Edwards pericardial valves in the mitral position: ten-year followup. J Thorac Cardiovasc Surg 1997;113:492-498. (Pubitemid 27149132)
10. Legarra JJ, Llorens R, Catalan M, Segura I, Trenor AM, de Buruaga JS, et al. Eighteen-year follow up after Hancock II bioprosthesis insertion. J Heart Valve Dis 1999;8:16-24. (Pubitemid 29077652)
11. Jamieson WR, Burr LH, Miyagishima RT, Germann E, Macnab JS, Stanford E, et al. Carpentier-Edwards supraannular aortic porcine bioprosthesis: clinical performance over 20 years. J Thorac Cardiovasc Surg 2005;130:994-1000. (Pubitemid 41427329)
12. Myken PS and Bech-Hansen O. A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis. J Thorac Cardiovasc Surg 2009;137:76-81.
13. Borger MA, Ivanov J, Armstrong S, Christie-Hrybinsky D, Feindel CM and David TE. Twenty-year results of the Hancock II bioprosthesis. J Heart Valve Dis 2006;15:49-56. (Pubitemid 43180525)
14. Jamieson WR, Marchand MA, Pelletier CL, Norton R, Pellerin M, Dubiel TW, et al. Structural valve deterioration in mitral replacement surgery: comparison of Carpentier-Edwards supra-annular porcine and Perimount pericardial bioprostheses. J Thorac Cardiovasc Surg 1999;118:297-304.
15. Jamieson WR, Gudas VM, Burr LH, Janusz MT, Fradet GJ, Ling H, et al. Mitral valve disease: if mitral valve is not reparable/failed repair, is bioprosthesis suitable for replacement [Review]? Eur J Cardiothorac Surg 2009;35:104-110.
16. Yu HY, Ho YL, Chu SH, Chen YS, Wang SS and Lin FY. Long-term evaluation of Carpentier-Edwards porcine bioprosthesis for rheumatic heart disease. J Thorac Cardiovasc Surg 2003;126:80-89.
17. Pomar JL, Jamieson WR, Pelletier LC, Gerein AN, Castella M and Brownlee RT. Mitroflow pericardial bioprosthesis: clinical performance to ten years. Ann Thorac Surg 1995;60: S305-S309.
18. Kurlansky PA, Williams DB, Traad EA, Carrillo RG, Schor JS, Zucker M, et al. The valve of choice in elderly patients and its influence on quality of life: a long-term comparative study. J Heart Valve Dis 2006;15:180-189.
19. Marchand MA, Aupart MR, Norton R, Goldsmith IR, Pelletier LC, Pellerin M, et al. Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis. Ann Thorac Surg 2001;71:236-239.
20. Horstkotte D, Schulte H, Bircks W and Strauer B. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow-up of patients with St. Jude Medical prostheses. J Heart Valve Dis 1993;2:291-301.